Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Carnival prices $1bn private offering in bid to cut interest expense

(Sharecast News) - Cruise giant Carnival priced a $1bn private offering of 5.75% senior unsecured notes due 2030 overnight, it announced on Wednesday morning, as part of its ongoing effort to lower borrowing costs. The FTSE 250 company said it intended to use the proceeds, alongside existing cash, to redeem its existing $1bn 10.5% senior unsecured notes due 2030.

It said the transaction would reduce its annual net interest expenses by about $45m, adding that the new notes would be governed by an indenture with investment grade-style covenants.

The offering was set to close on 28 February, subject to customary conditions, with the redemption of the existing notes planned for the same date, contingent on the completion of the new issue.

Carnival said the notes would pay interest semi-annually at a rate of 5.75% per year, with payments beginning on 15 September.

They would be unsecured and fully guaranteed on an unsecured basis by Carnival and certain subsidiaries that also backed the company's first-priority secured debt, other unsecured notes, and convertible notes.

At 0818 GMT, shares in Carnival were down 1.66% at 1,814.5p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.